Method for timing a colonoscopy

• US 9,669,110 B2
• Filed: 07/16/2012
• Issued: 06/06/2017
• Est. Priority Date: 07/15/2011
• Status: Active Grant

• Current Assignee: Ferring BV (Ferring Holding SA)
• Original Assignee: Ferring BV (Ferring Holding SA)
• Inventors: Joseph, Raymond E.
• Primary Examiner(s): Ziska, Suzanne
• Assistant Examiner(s): WHEELER, THURMAN MICHAEL
• Application Number:
  US13/549,889
• Publication Number:
  US 20130018223A1
• Time in Patent Office: 1,786 Days
• Field of Search: 600101, 424692
• CPC Class Codes: A61K 31/4402 only substituted in position 2, e.g. pheniramine, bisacodyl
• CPC Class Codes: A61K 49/00 Preparations for testing in vivo
• CPC Class Codes: A61P 1/00 Drugs for disorders of the alimentary tract or the digestive system
• CPC Class Codes: A61P 1/10 Laxatives
• CPC Class Codes: A61P 43/00 Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Based on the present disclosure, a minimal time interval can be achieved between the last ingestion of a picosulfate composition and the performance of the colonoscopy. For example, the present disclosure is directed to a method of timing a colonoscopy procedure performed on a patient in need thereof, comprising: administering, to the patient, a picosulfate bowel composition kit according to the kit'"'"'s instructions; performing the procedure less than about 4 hours after the administration of the kit.

Claims

1. A method of timing a colonoscopy procedure performed on a patient in need thereof, comprising:

administering a picosulfate bowel composition to the patient; and

performing the colonoscopy procedure from about 3 hours to about 1 hour after the administration of the picosulfate bowel composition.

2. The method according to claim 1, wherein the step of performing the colonoscopy procedure occurs from about 3 hours to about 2 hours after the administration of the picosulfate bowel composition.

3. The method according to claim 1, wherein the picosulfate bowel composition is prepared from a mixture comprising sodium picosulfate, magnesium oxide, and citric acid.

4. The method according to claim 1, further comprising administering clear liquids to the patient following the administration of the picosulfate bowel composition.

5. The method according to claim 1, wherein the picosulfate bowel composition is part of a picosulfate bowel composition kit further comprising instructions for preparing the picosulfate bowel composition for administration.

16. The method according to claim 1, wherein the picosulfate bowel composition comprises sodium picosulfate and magnesium citrate.

19. The method according to claim 16, wherein the bowel composition is prepared from a mixture comprising sodium picosulfate, magnesium oxide, and citric acid.

20. The method according to claim 16, wherein the method comprises administering clear liquids to the patient after administering the picosulfate bowel composition.

6. A method of timing a colonoscopy procedure performed on a patient in need thereof, comprising:

administering a first picosulfate bowel composition to the patient the day before the colonoscopy procedure;

administering a second picosulfate bowel composition to the patient on the day of the colonoscopy procedure; and

performing the colonoscopy procedure from about 3 hours to about 1 hour after the administration of the second picosulfate bowel composition.

7. The method according to claim 6, wherein the step of performing the colonoscopy procedure occurs from about 3 hours to about 2 hours after the administration of the second picosulfate bowel composition.

8. The method according to claim 6, wherein the first and the second picosulfate bowel compositions are each prepared from a mixture comprising sodium picosulfate, magnesium oxide, and citric acid.

9. The method according to claim 6, further comprising administering clear liquids to the patient following at least one of the first and the second administrations of the picosulfate bowel compositions.

10. The method according to claim 6, wherein the first and second picosulfate bowel compositions are part of a picosulfate bowel composition kit further comprising instructions for preparing the picosulfate bowel compositions for administration.

17. The method according to claim 6, wherein the first and second picosulfate bowel compositions each comprise sodium picosulfate and magnesium citrate.

21. The method according to claim 17, wherein the first and second picosulfate bowel composition are each prepared from a mixture comprising sodium picosulfate, magnesium oxide, and citric acid.

22. The method according to claim 17, wherein the method comprises administering clear liquids to the patient after administering the first picosulfate bowel composition, after administering the second picosulfate bowel composition, or both.

11. A method of timing a colonoscopy procedure performed on a patient in need thereof, the method consisting essentially of:

administering a first picosulfate bowel composition to the patient on the day before the colonoscopy procedure; and

administering a second picosulfate bowel composition to the patient on the day of the colonoscopy procedure from about 3 hours to about 1 hour prior to the colonoscopy procedure, and

optionally administering clear liquids to the patient following the least one of the first and second administrations of the picosulfate bowel compositions.

12. The method according to claim 11, wherein the step of administering the second picosulfate bowel composition occurs from about 3 hours to about 2 hours prior to the procedure.

13. The method according to claim 11, wherein the first and the second bowel compositions are prepared from a mixture comprising sodium picosulfate, magnesium oxide, and citric acid.

14. The method according to claim 11, further comprising administering clear liquids to the patient following at least one of the first and the second administrations of the bowel compositions.

15. The method according to claim 11, wherein the first and second picosulfate bowel compositions are part of a picosulfate bowel composition kit further comprising instructions for preparing the picosulfate bowel compositions for administration.

18. The method according to claim 11, wherein the first and second picosulfate bowel compositions each comprise sodium picosulfate and magnesium citrate.

23. The method according to claim 18, wherein the first and second picosulfate bowel composition are each prepared from a mixture comprising sodium picosulfate, magnesium oxide, and citric acid.

24. The method according to claim 18, wherein the method comprises administering clear liquids to the patient after administering the first picosulfate bowel composition, after administering the second picosulfate bowel composition, or both.